Malta - English - Medicines Authority

indivior europe limited 27 windsor place, dublin 2, ireland - buprenorphine - sublingual tablet - buprenorphine 2 mg - other nervous system drugs

Malta - English - Medicines Authority

indivior europe limited 27 windsor place, dublin 2, ireland - buprenorphine - sublingual tablet - buprenorphine 8 mg - other nervous system drugs

Ireland - English - HPRA (Health Products Regulatory Authority)

indivior europe limited - buprenorphine hydrochloride - sublingual tablet - 0.4 milligram(s) - oripavine derivatives; buprenorphine

Ireland - English - HPRA (Health Products Regulatory Authority)

indivior europe limited - buprenorphine hydrochloride - sublingual tablet - 2 milligram(s) - oripavine derivatives; buprenorphine

Ireland - English - HPRA (Health Products Regulatory Authority)

indivior europe limited - buprenorphine hydrochloride - sublingual tablet - 8 milligram(s) - oripavine derivatives; buprenorphine

Ireland - English - HPRA (Health Products Regulatory Authority)

indivior europe limited - buprenorphine hydrochloride - sublingual tablet - 0.2 base milligrams - oripavine derivatives; buprenorphine

Ireland - English - HPRA (Health Products Regulatory Authority)

indivior europe limited - buprenorphine hydrochloride - solution for injection - 300 microgram(s)/millilitre - oripavine derivatives; buprenorphine

European Union - English - EMA (European Medicines Agency)

indivior europe limited - buprenorphine, naloxone - opioid-related disorders - other nervous system drugs - substitution treatment for opioid-drug dependence, within a framework of medical, social and psychological treatment. the intention of the naloxone component is to deter intravenous misuse. treatment is intended for use in adults and adolescents over 15 years of age who have agreed to be treated for addiction.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

indivior uk ltd - naloxone hydrochloride dihydrate; buprenorphine hydrochloride - sublingual tablet - 500microgram ; 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

indivior uk ltd - naloxone hydrochloride dihydrate; buprenorphine hydrochloride - sublingual tablet - 2mg ; 8mg